Jordi Sevilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jordi Sevilla has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Vergara
Microbiology Department, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain; Institute of Global Health (ISGlobal), Barcelona, Spain; CIBERINFEC, CIBER in Infectious Diseases, ISCIII, Madrid, Spain; University of Barcelona, Faculty of Medicine, Barcelona, Spain
1 shared publication - Fernando González-Candelas
Unidad Mixta Infección y Salud Pública FISABIO, Universidad de Valencia-I2SysBio, Valencia, Spain
1 shared publication - Iñaki Comas
Institute of Biomedicine of Valencia IBV-CSIC
1 shared publication - Jordi Vila
Barcelona Institute for Global Health (ISGlobal), Hospital Clinic, University of Barcelona, Barcelona, Spain; CIBERINFEC, Instituto Salud Carlos III, Madrid, Spain
1 shared publication - Julia Kende
Institut Pasteur
1 shared publication Michael T Meehan
James Cook University
1 shared publication
Latest Publications
- Open Access
Quantifying superspreading in bacterial STI outbreaks using phylodynamics
Bacterial sexually transmitted infections (STIs) pose a major global public health challenge, with Neisseria gonorrhoeae being of particular concern due to its persistently high prevalence and increasing antimicrobial resistance. The emergence of multidrug-resistant strains has narrowed treatment options, highlighting the importance of prevention. In this context, knowing whether there is superspreading (transmission heterogeneity) within a population becomes crucial for accurate public health measures. However, classic methods to quantify superspreading rely on dense contact tracing, and this is not always feasible. As an alternative, we can use Bayesian phylodynamic modelling to infer transmission dynamics, including superspreading. Yet modelling transmission dynamics using bacterial data remains problematic, although it is widely used for viral data. Here, we apply a multi-type birth-death model parametrised to quantify superspreading in N. gonorrhoeae outbreaks, estimating the fraction and relative impact of superspreaders and reproductive numbers for superspreaders and non-superspreaders. We also use a hierarchical modelling strategy with partial pooling to increase the power for detecting superspreading in each cluster. Model performance was successfully evaluated across a range of superspreading scenarios using both transmission-informed phylogenies and sequence data with phylogenetic uncertainty. Application to empirical genomic data revealed a substantial role of superspreading in N. gonorrhoeae transmission during the COVID-19 pandemic in Australia. These results highlight the impact of superspreading in N. gonorrhoeae transmission and the importance of detecting it to efficiently stop the dissemination of the disease
Open AccessQuantifying superspreading in bacterial STI outbreaks using phylodynamics
Bacterial sexually transmitted infections (STIs) pose a major global public health challenge, with Neisseria gonorrhoeae being of particular concern due to its persistently high prevalence and increasing antimicrobial resistance. The emergence of multidrug-resistant strains has narrowed treatment options, highlighting the importance of prevention. In this context, knowing whether there is superspreading (transmission heterogeneity) within a population becomes crucial for accurate public health measures. However, classic methods to quantify superspreading rely on dense contact tracing, and this is not always feasible. As an alternative, we can use Bayesian phylodynamic modelling to infer transmission dynamics, including superspreading. Yet modelling transmission dynamics using bacterial data remains problematic, although it is widely used for viral data. Here, we apply a multi-type birth-death model parametrised to quantify superspreading in N. gonorrhoeae outbreaks, estimating the fraction and relative impact of superspreaders and reproductive numbers for superspreaders and non-superspreaders. We also use a hierarchical modelling strategy with partial pooling to increase the power for detecting superspreading in each cluster. Model performance was successfully evaluated across a range of superspreading scenarios using both transmission-informed phylogenies and sequence data with phylogenetic uncertainty. Application to empirical genomic data revealed a substantial role of superspreading in N. gonorrhoeae transmission during the COVID-19 pandemic in Australia. These results highlight the impact of superspreading in N. gonorrhoeae transmission and the importance of detecting it to efficiently stop the dissemination of the disease
- Open Access
VIPERA: Viral Intra-Patient Evolution Reporting and Analysis
Viral mutations within patients nurture the adaptive potential of SARS-CoV-2 during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein we describe VIPERA (Viral Intra-Patient Evolution Reporting and Analysis), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. We have validated it using positive and negative control datasets and have successfully applied it to a new case, thus enabling an easy and automatic analysis of intra-patient SARS-CoV-2 sequences.
Open AccessVIPERA: Viral Intra-Patient Evolution Reporting and Analysis
Viral mutations within patients nurture the adaptive potential of SARS-CoV-2 during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein we describe VIPERA (Viral Intra-Patient Evolution Reporting and Analysis), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. We have validated it using positive and negative control datasets and have successfully applied it to a new case, thus enabling an easy and automatic analysis of intra-patient SARS-CoV-2 sequences.